Panadol Femina (Paracetamol, Hyoscine Butylbromide)

Paracetamol, the active ingredient in Panadol Femina, is an analgesic and antipyretic presented as a tablet for oral use. It relieves mild to moderate pain and reduces fever in adults and children. Hyoscine Butylbromide, the active ingredient in Panadol Femina, is an antispasmodic presented as a tablet for oral use. It alleviates abdominal cramping and related gastrointestinal discomfort.

GNH USA supplies Panadol Femina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Panadol Femina combines paracetamol and hyoscine butylbromide to address pain and smooth‑muscle spasm pathways. - Menstrual pain: Provides relief from dysmenorrhoea associated with uterine cramping. - Headache and fever: Reduces pain intensity and lowers elevated body temperature. - Gastro‑intestinal cramping: Relieves abdominal discomfort caused by spasms of the gastrointestinal tract.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea: mild stomach upset that may occur after ingestion. - Dizziness: transient feeling of light‑headedness. - Dry mouth: reduced salivation leading to a dry sensation. - Blurred vision: temporary visual disturbance. - Constipation: slowed intestinal transit.

Serious or Rare Side Effects: - Hepatotoxicity: potential liver injury with excessive paracetamol exposure. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Acute glaucoma: sudden increase in intra‑ocular pressure, particularly in susceptible individuals. - Cardiac arrhythmia: irregular heartbeat linked to anticholinergic effects. - Anaphylaxis: life‑threatening systemic allergic response.

Before using Panadol Femina, consider the following safety measures. - Liver function monitoring: assess hepatic health in patients with chronic liver disease or high alcohol intake. - Alcohol consumption: limit intake as it may increase risk of liver toxicity. - Pregnancy and lactation: consult a healthcare professional before use. - Age restrictions: avoid use in children under the recommended age without medical advice. - Concomitant medications: review other drugs for overlapping paracetamol content. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Panadol Femina may interact with several medicines; monitoring is advised.

Major Interactions (Avoid): - Warfarin: increased bleeding risk due to enhanced anticoagulant effect. - Isoniazid: heightened risk of liver toxicity when combined with paracetamol.

Moderate Interactions (Monitor Closely): - Antihistamines: additive anticholinergic effects may increase dry mouth and constipation. - Tricyclic antidepressants: may potentiate anticholinergic side effects. - Metoclopramide: combined anticholinergic action can exacerbate gastrointestinal motility issues.